The Impact of COVID-19 Pandemic on Intimate Partner Violence (IPV) Against Women.
Ijeoma C UzohoKesha Baptiste-RobertsAdeola AnimasahunYvonne BronnerPublished in: International journal of social determinants of health and health services (2023)
Intimate partner violence (IPV) is a global public health crisis associated with adverse physical, psychological, economic, and social consequences. Studies on the impact of COVID-19 on IPV against women are scarce. This study aimed to understand the impact of COVID-19 on IPV against women. Google Scholar, PubMed, and the Cochrane Library were searched using the MeSH terms intimate partner violence, COVID-19, and women. Exclusion criteria were male-partner, elder, and child abuse and studies that targeted specific groups such as cancer, HIV, and substance abuse. Two independent reviewers completed the title, abstract screening, and review of selected articles. Thirteen out of 647 articles met the inclusion criteria. IPV against women increased in nine countries (Spain, United States, Nigeria, Ethiopia, Turkey, Peru, Bangladesh, Czech Republic, and the Democratic Republic of Congo); one country showed no change in gender-based violence among adolescent girls and young women (Kenya); and one study reported a decrease in IPV reporting by victims (United States). Policies made to mitigate the pandemic created unintended consequences that exacerbated risk factors for IPV against women. Lessons learned from COVID-19 must be used to develop policy-level support and response services to mitigate IPV against women amid a pandemic and other human crises.
Keyphrases
- intimate partner violence
- coronavirus disease
- sars cov
- polycystic ovary syndrome
- public health
- pregnancy outcomes
- mental health
- cervical cancer screening
- healthcare
- insulin resistance
- endothelial cells
- primary care
- type diabetes
- drug delivery
- pregnant women
- adipose tissue
- antiretroviral therapy
- hiv aids
- hiv infected
- case control
- pluripotent stem cells